Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Devashish Tripathi"'
Autor:
Suman Kalyan Paine, Usha Kiran Rout, Chandrika Bhattacharyya, Debaprasad Parai, Mahabub Alam, Rasmi Ranjan Nanda, Devashish Tripathi, Parveena Choudhury, Chanakya Nath Kundu, Sanghamitra Pati, Debdutta Bhattacharya, Analabha Basu
Publikováno v:
npj Biofilms and Microbiomes, Vol 8, Iss 1, Pp 1-9 (2022)
Abstract The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has posed multiple challenges to global public health. Clinical features and sequela of SARS-CoV-2 infection include long-term and short-term complications often clini
Externí odkaz:
https://doaj.org/article/f057ec9846f043f3b658d0b213b6a421
Autor:
Chandrika Bhattacharyya, Diganta Barman, Devashish Tripathi, Soumita Dutta, Chandra Bhattacharya, Mahabub Alam, Parveena Choudhury, Utpala Devi, Jagadish Mahanta, Reeta Rasaily, Analabha Basu, Suman K. Paine
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 3 (2023)
ABSTRACT It is believed that establishment of the gut microbiome starts very early in life and is crucial for growth, immunity, and long-term metabolic health. In this longitudinal study, we recruited 25 mothers in their third trimester, of whom 15 h
Externí odkaz:
https://doaj.org/article/fe8b9643bf2048c490b41535f8ada8d4
Autor:
Waseem Abbas, Saurabh Gupta, Vineeta Goel, Ranga R. Rao, Promila Pankaj, Devashish Tripathi, Pratik P. Patil, Swati Popli
Publikováno v:
South Asian Journal of Cancer, Vol 10, Iss 02, Pp 72-75 (2021)
Background Recurrent metastatic head and neck squamous cell carcinoma (HNSCC) patients carry a poor prognosis and have limited therapeutic options. In the randomized phase-3 trial CheckMate 141, nivolumab showed benefit in overall survival (OS) with
Externí odkaz:
https://doaj.org/article/d238663aa8dd4114b39fbab5b780cedc
Autor:
Promila Pankaj, Pratik Patil, Swati Popli, Ranga R. Rao, Vineeta Goel, Saurabh Gupta, Devashish Tripathi, Waseem Abbas
Publikováno v:
South Asian Journal of Cancer, Vol 10, Iss 02, Pp 72-75 (2021)
Background Recurrent metastatic head and neck squamous cell carcinoma (HNSCC) patients carry a poor prognosis and have limited therapeutic options. In the randomized phase-3 trial CheckMate 141, nivolumab showed benefit in overall survival (OS) with
Autor:
Devashish Tripathi, Pavithra Gayani
Publikováno v:
Clinical Oncology. 34:e16-e17
Autor:
Suman Kalyan Paine, Usha Kiran Rout, Chandrika Bhattacharyya, Debaprasad Parai, Mahabub Alam, Rasmi Ranjan Nanda, Devashish Tripathi, Parveena Choudhury, Chanakya Nath Kundu, Sanghamitra Pati, Debdutta Bhattacharya, Analabha Basu
Publikováno v:
NPJ biofilms and microbiomes. 8(1)
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has posed multiple challenges to global public health. Clinical features and sequela of SARS-CoV-2 infection include long-term and short-term complications often clinically ind
Publikováno v:
Document Analysis and Recognition – ICDAR 2021 Workshops ISBN: 9783030861582
ICDAR Workshops (2)
ICDAR Workshops (2)
In this work, we propose an end-to-end language agnostic multi-task learning based U-Net framework for performing text block segmentation and baseline detection in document images. We leverage the performance of U-Net by augmenting attention layers b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d364661510e24f71420d6b6870cbdddf
https://doi.org/10.1007/978-3-030-86159-9_32
https://doi.org/10.1007/978-3-030-86159-9_32
Autor:
Harm van Tinteren, Kate Haslett, Astrid Keijser, Annija van der Leest, Egbert F. Smit, Bart Reymen, Matthew Hatton, Suresh Senan, Iris E. van Dam, Jos A. Stigt, Ben J. Slotman, J. Knegjens, Corinne Faivre-Finn, Devashish Tripathi, J. Praag
Publikováno v:
Lung Cancer, 108, 150-153. ELSEVIER IRELAND LTD
Lung Cancer, 108, 150-153. Elsevier Ireland Ltd
Slotman, B J, Faivre-Finn, C, van Tinteren, H, Keijser, A, Praag, J, Knegjens, J, Hatton, M, van Dam, I, van der Leest, A, Reymen, B, Stigt, J, Haslett, K, Tripathi, D, Smit, E F & Senan, S 2017, ' Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy : A secondary analysis of the Phase III CREST trial ', Lung Cancer, vol. 108, pp. 150-153 . https://doi.org/10.1016/j.lungcan.2017.03.007
Slotman, B J, Faivre-Finn, C, van Tinteren, H, Keijser, A, Praag, J O, Knegjens, J, Hatton, M, van Dam, I, van der Leest, A, Reymen, B, Stigt, J A, Haslett, K, Tripathi, D, Smit, E F & Senan, S 2017, ' Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy : A secondary analysis of the Phase III CREST trial ', Lung Cancer, vol. 108, pp. 150–153 . https://doi.org/10.1016/j.lungcan.2017.03.007
Lung Cancer, 108, 150-153. Elsevier Ireland Ltd
Slotman, B J, Faivre-Finn, C, van Tinteren, H, Keijser, A, Praag, J, Knegjens, J, Hatton, M, van Dam, I, van der Leest, A, Reymen, B, Stigt, J, Haslett, K, Tripathi, D, Smit, E F & Senan, S 2017, ' Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy : A secondary analysis of the Phase III CREST trial ', Lung Cancer, vol. 108, pp. 150-153 . https://doi.org/10.1016/j.lungcan.2017.03.007
Slotman, B J, Faivre-Finn, C, van Tinteren, H, Keijser, A, Praag, J O, Knegjens, J, Hatton, M, van Dam, I, van der Leest, A, Reymen, B, Stigt, J A, Haslett, K, Tripathi, D, Smit, E F & Senan, S 2017, ' Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy : A secondary analysis of the Phase III CREST trial ', Lung Cancer, vol. 108, pp. 150–153 . https://doi.org/10.1016/j.lungcan.2017.03.007
Introduction: In ES-SCLC patients with residual intrathoracic disease after first-line chemotherapy, the addition of thoracic radiotherapy reduces the risk of intrathoracic recurrence, and improves 2-year survival. To identify patient subgroups for f
Autor:
Abraham, Jean E., Pinilla, Karen, Dayimu, Alimu, Grybowicz, Louise, Demiris, Nikolaos, Harvey, Caron, Drewett, Lynsey M., Lucey, Rebecca, Fulton, Alexander, Roberts, Anne N., Worley, Joanna R., Chhabra, Anita, Qian, Wendi, Vallier, Anne-Laure, Hardy, Richard M., Chan, Steve, Hickish, Tamas, Tripathi, Devashish, Venkitaraman, Ramachandran, Persic, Mojca
Publikováno v:
Nature; May2024, Vol. 629 Issue 8014, p1142-1148, 7p
Autor:
Paine, Suman Kalyan, Rout, Usha Kiran, Bhattacharyya, Chandrika, Parai, Debaprasad, Alam, Mahabub, Nanda, Rasmi Ranjan, Tripathi, Devashish, Choudhury, Parveena, Kundu, Chanakya Nath, Pati, Sanghamitra, Bhattacharya, Debdutta, Basu, Analabha
Publikováno v:
NPJ Biofilms & Microbiomes; 8/24/2022, Vol. 8 Issue 1, p1-9, 9p